These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27255678)

  • 21. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.
    Suntharalingam M; Paulus R; Edelman MJ; Krasna M; Burrows W; Gore E; Wilson LD; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):456-63. PubMed ID: 22543206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.
    Arbea L; Martínez-Monge R; Díaz-González JA; Moreno M; Rodríguez J; Hernández JL; Sola JJ; Ramos LI; Subtil JC; Nuñez J; Chopitea A; Cambeiro M; Gaztañaga M; García-Foncillas J; Aristu J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):587-93. PubMed ID: 22079731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma.
    O'Sullivan B; Griffin AM; Dickie CI; Sharpe MB; Chung PW; Catton CN; Ferguson PC; Wunder JS; Deheshi BM; White LM; Kandel RA; Jaffray DA; Bell RS
    Cancer; 2013 May; 119(10):1878-84. PubMed ID: 23423841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis.
    Gingrich AA; Bateni SB; Monjazeb AM; Darrow MA; Thorpe SW; Kirane AR; Bold RJ; Canter RJ
    Ann Surg Oncol; 2017 Oct; 24(11):3252-3263. PubMed ID: 28741123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.
    Mullen JT; Kobayashi W; Wang JJ; Harmon DC; Choy E; Hornicek FJ; Rosenberg AE; Chen YL; Spiro IJ; DeLaney TF
    Cancer; 2012 Aug; 118(15):3758-65. PubMed ID: 22180344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection.
    Jakob J; Tunn PU; Hayes AJ; Pilz LR; Nowak K; Hohenberger P
    J Surg Oncol; 2014 Jun; 109(8):786-90. PubMed ID: 24619722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303.
    De Sanctis R; Giordano L; Colombo C; De Paoli A; Navarria P; Sangalli C; Buonadonna A; Sanfilippo R; Bertola G; Fiore M; Marrari A; Navarria F; Bertuzzi A; Casali PG; Basso S; Santoro A; Quagliuolo V; Gronchi A
    Ann Surg Oncol; 2017 Dec; 24(13):3872-3879. PubMed ID: 29043525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery.
    Rini BI; Garcia J; Elson P; Wood L; Shah S; Stephenson A; Salem M; Gong M; Fergany A; Rabets J; Kaouk J; Krishnamurthi V; Klein E; Dreicer R; Campbell S
    J Urol; 2012 May; 187(5):1548-54. PubMed ID: 22425095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma.
    Nowak AK; Millward MJ; Creaney J; Francis RJ; Dick IM; Hasani A; van der Schaaf A; Segal A; Musk AW; Byrne MJ
    J Thorac Oncol; 2012 Sep; 7(9):1449-56. PubMed ID: 22895142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma.
    Grivas PD; Daignault S; Tagawa ST; Nanus DM; Stadler WM; Dreicer R; Kohli M; Petrylak DP; Vaughn DJ; Bylow KA; Wong SG; Sottnik JL; Keller ET; Al-Hawary M; Smith DC; Hussain M
    Cancer; 2014 Mar; 120(5):692-701. PubMed ID: 24249435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Pazopanib in High-Risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04).
    Ronellenfitsch U; Karampinis I; Dimitrakopoulou-Strauss A; Sachpekidis C; Jakob J; Kasper B; Nowak K; Pilz L; Attenberger U; Gaiser T; Derigs HG; Schwarzbach M; Hohenberger P
    Ann Surg Oncol; 2019 May; 26(5):1332-1339. PubMed ID: 30843160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of time interval between preoperative radiation and surgical resection on the development of wound healing complications in extremity soft tissue sarcoma.
    Griffin AM; Dickie CI; Catton CN; Chung PW; Ferguson PC; Wunder JS; O'Sullivan B
    Ann Surg Oncol; 2015 Sep; 22(9):2824-30. PubMed ID: 26018726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.
    Tong CC; Ko EC; Sung MW; Cesaretti JA; Stock RG; Packer SH; Forsythe K; Genden EM; Schwartz M; Lau KH; Galsky M; Ozao-Choy J; Chen SH; Kao J
    PLoS One; 2012; 7(6):e36979. PubMed ID: 22761653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of safety and tolerability of sunitinib in combination with sirolimus in patients with refractory solid malignancies and determination of VEGF (VEGF-A) and soluble VEGF-R2 (sVEGFR2) in plasma.
    Li J; Kluger H; Devine L; Lee JJ; Kelly WK; Rink L; Saif MW
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1193-200. PubMed ID: 27103123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03).
    Jakob J; Lesluyes T; Simeonova-Chergou A; Wenz F; Hohenberger P; Chibon F; Le Guellec S
    Strahlenther Onkol; 2020 Mar; 196(3):280-285. PubMed ID: 31732782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Vestermark LW; Jensen HA; Pfeiffer P
    Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
    Alektiar KM; Brennan MF; Healey JH; Singer S
    J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.
    Jebsen NL; Bruland ØS; Eriksson M; Engellau J; Turesson I; Folin A; Trovik CS; Hall KS
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1359-66. PubMed ID: 20933339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery.
    Silberstein JL; Millard F; Mehrazin R; Kopp R; Bazzi W; DiBlasio CJ; Patterson AL; Downs TM; Yunus F; Kane CJ; Derweesh IH
    BJU Int; 2010 Nov; 106(9):1270-6. PubMed ID: 20394613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.